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Abstract
Background
Anterior segment dysgenesis (ASD) disorders are a group of clinically and genetically het-
erogeneous phenotypes in which frequently cornea, iris, and lens are affected. This study
aimed to identify novel mutations in PAX6, PITX2 and FOXC1 in families with anterior seg-
ment dysgenesis disorders.
Methods
We studied 14 Pakistani and one Mexican family with Axenfeld Rieger syndrome (ARS;
n = 10) or aniridia (n = 5). All affected and unaffected family members underwent full oph-
thalmologic and general examinations. Total genomic DNA was isolated from peripheral
blood. PCR and Sanger sequencing were performed for the exons and intron-exon bound-
aries of the FOXC1, PAX6, and PITX2 genes.
Results
Mutations were identified in five of the 15 probands; four variants were novel and one vari-
ant was described previously. A novel de novo variant (c.225C>A; p.Tyr75*) was identified
in the PAX6 gene in two unrelated probands with aniridia. In addition, a known variant
(c.649C>T; p.Arg217*) in PAX6 segregated in a family with aniridia. In the FOXC1 gene, a
novel heterozygous variant (c.454T>C; p.Trp152Arg) segregated with the disease in a Mex-
ican family with ARS. A novel homozygous variant (c.92_100del; p.Ala31_Ala33del) in the
FOXC1 gene segregated in a Pakistani family with ARS and congenital glaucoma.
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Conclusions
Our study expands the mutation spectrum of the PAX6 and FOXC1 genes in individuals with
anterior segment dysgenesis disorders. In addition, our study suggests that FOXC1muta-
tions, besides typical autosomal dominant ARS, can also cause ARS with congenital glau-
coma through an autosomal recessive inheritance pattern. Our results thus expand the
disease spectrum of FOXC1, and may lead to a better understanding of the role of FOXC1
in development.
Introduction
Anterior segment dysgenesis (ASD) disorders encompass a wide variety of developmental con-
ditions in which multiple tissues such as the cornea, iris, and lens are affected [1]. The anterior
segment consists of the anterior chamber and the posterior chamber, which are separated by
the iris. In the posterior chamber, the ciliary body produces the aqueous humor which provides
essential nutrients to the tissues of the anterior segment [2–4]. The aqueous humor is partially
drained by the trabecular meshwork, and Schlemm's canal drainage structures located at the
anterior segment angle where the iris and cornea meet. These structures that regulate the aque-
ous humor flow can be affected in patients with anterior segment dysgenesis, which leads to
glaucoma in approximately 50% of the cases. These abnormalities may result from the abnor-
mal differentiation of the mesenchymal cells which are responsible for the cornea, iris, and
drainage structures development [2–4].
ASD have been classified into different subtypes: aniridia, Axenfeld-Rieger syndrome
(ARS), Peters' anomaly (PA), iridogoniodysgenesis, and posterior embryotoxon. They can be
inherited either through autosomal recessive or autosomal dominant modes of inheritance,
often with incomplete penetrance. Aniridia is a rare congenital disorder of either partial or
complete hypoplasia of the iris, and can be associated with other eye defects such as corneal
opacification, cataract, glaucoma, lens dislocation, ciliary body hypoplasia, foveal hypoplasia,
strabismus, and nystagmus [5–7]. In about two-third of cases it is inherited as an autosomal
dominant trait [8, 5]. ARS is a heterogeneous disorder characterized by a broad range of ocular
and systemic abnormalities. Ocular features observed in ARS patients include iris stromal
hypoplasia, polycoria, corectopia, iridogoniodysgenesis, posterior embryotoxon and iris
strands bridging the iridocorneal angle to the trabecular meshwork. The various systemic fea-
tures observed in ARS patients include facial dysmorphisms (e.g. hypertelorism, prominent
forehead, telecanthus), dental anomalies (e.g. hypodontia, microdontia) and a redundant pre-
umbilical skin [9, 10]. Mutations in the PAX6, PITX2, and FOXC1 genes have been associated
with aniridia and ARS in an autosomal dominant manner [11–16].
The aim of the current study was to identify the genetic causes of aniridia and ARS in 15
Pakistani and Mexican families.
Materials and Methods
Ethics statement
This study was approved by the Institutional Review Board of the Pediatric Glaucoma depart-
ment of Al-Shifa Eye Trust Hospital, Pakistan and the Genetics department of the Asociación
Para Evitar la Ceguera en México, Mexico. Written informed consent that complied with
the tenets of the Declaration of Helsinki was obtained from every affected and unaffected
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individual (or his/her guardian) before they were enrolled into the study. The individuals in
this manuscript has given written informed consent (as outlined in PLOS consent form) to
publish these case details.
Subjects
Blood samples were collected from affected and unaffected siblings, and from the parents of 14
Pakistani and one Mexican family with anterior segment dysgenesis disorders (ARS n = 10,
aniridia n = 5). Genomic DNA was extracted using AutoPure LS DNA Extractor and PURE-
GEN reagents (Gentra Systems Inc, Minneapolis, Minnesota, USA).
Polymerase chain reaction and Sanger Sequencing
All coding exons and intron-exon boundaries of the PAX6, PITX2 and FOXC1 genes were
amplified by standard polymerase chain reaction (PCR) (primer sequences available on
request). The PCR products were Sanger sequenced using ABI BigDye chemistry (Applied Bio-
systems Inc, Foster City, California, USA), and were processed through an automated ABI
3730 Sequencer (Applied Biosystems, Inc. The sequencing results were aligned with the con-
sensus sequences using Vector NTI Advance™ 2011 software from Life Technologies/Invitro-
gen (Bleiswijk, Netherlands), by assembling the sequenced contigs. Variants were named
according to the nomenclature recommended by the Human Genomic Variation Society
(HGVS). Cosegregation analysis was carried out in available family members. The possible
effects of variants were predicted by Polymorphism Phenotyping (PolyPhen-2, http://genetics.
bwh.harvard.edu/pph2/) and Sorting Intolerant Form Tolerant (SIFT; http://sift.jcvi.org/),
PhyloP, Grantham, and MutationTaster.
Results
Identification of PAX6mutations in three probands with aniridia
The proband (II:3) of family 1 (Fig 1) from Pakistan was a 5-year old girl affected with bilateral
aniridia, glaucoma, superiorly subluxated lenses, and cataract in the left eye (Fig 1). She under-
went bilateral glaucoma surgery and lensectomy. Both parents had normal ocular examinations
with 6/6 vision in both eyes. A novel heterozygous nonsense mutation (c.225C>A; p.Tyr75)
in the PAX6 gene was identified in the proband. The variant was not detected in parents, sug-
gesting that it arose de novo in the proband (Fig 1).
The same variation (c.225C>A; p.Tyr75) was identified in another unrelated 2-year-old
girl from Pakistan with bilateral aniridia, corneal opacity and buphthalmos. Her left eye was
prosthetic after enucleation. Unfortunately DNA samples of her parents were not available.
Proband II:1 of family 2 (Fig 2) from Pakistan was an 8-year-old boy presenting with aniri-
dia, foveal hypoplasia, aphakia, hazy cornea, cataract and nystagmus. He also had signs of lim-
bal stem cell deficiency and was mentally retarded. His 30-year-old brother (II:2) had similar
clinical findings except mental retardation. The mother (I:2) of the proband had no vision in
the left eye and had complete aniridia of the right eye. A heterozygous nonsense mutation
(c.649C>T; p.Arg217) in the PAX6 gene was detected in the proband, and segregated with the
disease in the affected mother and brother of the proband (Fig 2).
Identification of FOXC1mutations in two probands with ARS
The proband (II:1) of family 3 (Fig 3A) fromMexico was diagnosed with ARS and congenital
glaucoma at the age of 6 years. She had a prosthesis of her left eye (Fig 3B and 3C). At the age
of 13 years, physical examination showed midface hypoplasia, a flat nose, hypertelorism,
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Fig 1. Family 1 from Pakistan with aniridia due to a de novo heterozygous PAX6mutation. (A) Pedigree and segregation of a novel mutation
(c.225C>A; p.Tyr75*) in the PAX6 gene. (B). Clinical presentation of the affected proband (II:3), corneal neovascularization and opacification in the right and
left eyes. (C). DNA sequence chromatogram of PAX6.
doi:10.1371/journal.pone.0160016.g001
Fig 2. Family 2 from Pakistan with aniridia due to a heterozygous PAX6mutation. (a) Pedigree and segregation of a previously described mutation
(c.649C>T; p.Arg217*) in the PAX6 gene. (b). DNA sequence chromatogram of PAX6 for the variant c.649C>T.
doi:10.1371/journal.pone.0160016.g002
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telecanthus, enamel hypoplasia and mild deafness. Her 9-year-old brother (II:2) (Fig 3D and
3E) and father (I:1) had similar clinical characteristics. A novel missense variant (c.454T>C; p.
Trp152Arg) was identified in the FOXC1 gene (Fig 3F). The PhyloP score was 4.16 and the
Grantham distance was 101. The mutated tryptophan amino acid was conserved among differ-
ent species (Fig 3G).
Proband II:1 of family 4 (Fig 4A) from Pakistan was a 4-year-old boy with partial aniridia,
aphakia, microcornea, cataract, and congenital glaucoma. His 9-year-old brother (II:2) had
the similar clinical findings of microcornea, poor vision, and glaucoma. He also had sclero-
cornea and nystagmus and his left eye was phthisical after surgery for glaucoma. The anterior
chamber was not visible due to the corneal opacity. In this family a novel homozygous dele-
tion (c.92_100del; p.Ala31_Ala33del) in the FOXC1 gene segregated with the disease (Fig 4A
and 4B). The mutation leads to an in-frame deletion of three conserved alanine amino acids
(Fig 4C).
The variants identified in PAX6 and FOXC1 were predicted to be deleterious by SIFT, dam-
aging by Polyphen-2, and disease causing by MutationTaster. In addition the variants were
absent in public databases, including the dbSNP132, and Exome Aggregation Consortium
(ExAC).
Sanger sequencing of PITX2 gene did not revealed any variant in all the probands tested.
Fig 3. Family 3 fromMexico with ARS due to a heterozygous FOXC1mutation. (A) Pedigree and segregation of a novel missense mutation (c.454T>C;
p.Trp152Arg) in the FOXC1 gene. (B). Systemic and ocular characteristics of patient II.1 (C). Slit lamp photograph of right eye with posterior embriotoxon,
polycoria, corectopia and iris atrophy. (D). Systemic and ocular characteristics of patient II.2, Midface hypoplasia, thelecantus and broad nasal bridge. (E).
Slit lamp photographs of the right eye with posterior embriotoxon, polycoria, corectopia and iris atrophy. (F). Sequence chromatograph of the FOXC1 variant.
(G). Multiple sequence alignment of the region of the FOXC1 protein surrounding the novel p.Trp152Arg mutation in various species. The tryptophan residue
(indicated with an arrow) is highly conserved among all species analyzed.
doi:10.1371/journal.pone.0160016.g003
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Discussion
In the current study we report PAX 6mutations in two families and one unrelated proband
with aniridia. A novel de novomutation (c.225C>A; p.Tyr75) was identified in the PAX6
gene in one family, and the same mutation was identified in an unrelated 2-year old girl with
aniridia. In addition, a previously reported mutation (c.649C>T; p.Arg217) was identified in
the PAX6 gene [17] in another Pakistani family. PAX6 encodes a transcription factor consisting
of three domains; a paired domain at the NH2-terminus, a homeodomain in the middle, and a
transactivation at the COOH-terminus enriched with proline/serine/threonine. Pax6 is widely
expressed during normal eye development, [18] however, absence of Pax6 causes anophthalmia
in mice [19] and humans [20]. The normal development anterior segment of the eye is depen-
dent on the dose of the Pax6. Therefore, the PAX6+/− heterozygous null mutations responsible
for the haploinsufficiency in humans are characterized by aniridia and other ocular abnormali-
ties due to insufficient dose of Pax6 [14, 11, 21].
The majority (92%) of mutations identified to be associated with aniridia in the PAX6 gene
includes; one or two base pair deletions and insertions resulting a change in the reading frame
of the protein, nonsense, and splice site mutations [22–24]. In addition, a minority of mutations
are missense mutations (2%), which often cause different phenotypes than null mutations, such
as Peters anomaly [25], uveal ectropion [26], ectopia pupillae, cataracts, vascularized cornea,
elliptical anterior iris stromal defects and iris hypoplasia. One-third of mutations identified in
PAX6 are de novo (http://pax6.hgu.mrc.ac.uk/).
Fig 4. Family 4 from Pakistan with ARS and congenital glaucoma due to a homozygous FOXC1mutation. (a) Pedigree and segregation of a novel
deletion (c.92_100del; p.Ala31_Ala33del) in the FOXC1 gene. (b). DNA sequence chromatogram of FOXC1 demonstrating loss of codons Ala31-33.
doi:10.1371/journal.pone.0160016.g004
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In this study we also identified two novel mutations in the FOXC1 gene in two families with
ARS: a heterozygous missense mutation (c.454T>C; p.Trp152Arg), and a homozygous in-
frame deletion (c.92_100del; p.Ala31_Ala33del). In addition to the novel mutations in the
FOXC1 gene segregating with the disease, two known GGC triplet insertions polymorphisms
(rs545470261; p.Gly380dup and rs572346201; p.Gly456dup) that lead to a glycine incorpo-
ration have been identified in four probands, but none of them were segregating with the
disease.
The FOXC1 gene encodes a member of the forkhead box (FOX) family of transcription fac-
tors that are responsible for wide range of important roles such as embryogenesis, tissue-spe-
cific gene expression, and tumor development [27]. All forkhead transcription factors contains
a highly conserved forkhead DNA-binding domain (FHD). The wing-like structure of the
FHD is due to the particular arrangement of the alpha-helixes and beta-sheets. FOXC1 acti-
vates the target genes by recognizing and binding to specific DNA sequences in the target
genes through the conserved 110-amino-acid FHD [27]. The novel missense mutation (p.
Trp152Arg) identified in this study affects a conserved amino acid residue in the second β-
strand of the FOXC1 FHD. This mutation affects the same amino acid as the previously
reported p.Trp152Gly mutation in a patient with aniridia [28]. The p.Try152Gly mutation has
a severe effect on FOXC1 function, affecting its phosphorylation, protein folding, DNA-bind-
ing ability, and nuclear localization [28]. The p.Trp152Arg mutation may have a similar conse-
quence on the function of FOXC1. However, it is difficult to explain why there is a difference
in the phenotypes of the patients with these mutation as p.Trp152Arg mutation leads to ARS,
while the previously reported mutation p.Trp152Gly causes aniridia. Another FOXC1muta-
tion (p.Met161Lys) has been reported to cause both aniridia [12] and ARS [13, 29]. The pheno-
typic variability of overlapping FOXC1mutations suggests that perhaps other factors influence
the disease outcome.
In this study, we also identified a homozygous in-frame deletion (p.Ala31_Ala33del) of
three conserved alanine residues in a family with ARS and congenital glaucoma. These three
amino acids are located in the activation domain 1 (AD1) of the FOXC1 protein at the amino
terminus, which may affect the binding of FOXC1 with other interactors and may lead to irre-
sponsiveness to ligands that trigger the activation upon binding to the AD1. To date, only het-
erozygous FOXC1mutations have been reported in anterior segment dysgenesis disorders in
humans; the family described in this study is the first with a mutation segregating homozy-
gously. Previously, it has been reported that mice with heterozygous (Foxc1-/+) and homozy-
gous loss of Foxc1 (Foxc1-/-) have anterior segment abnormalities similar to those reported
in humans with ASD and congenital glaucoma, such as iris hypoplasia, small or absence of
Schlemm’s canal, severely eccentric pupils, displaced Schwalbe’s line, and aberrantly developed
TM [30]. However heterozygous (Foxc1-/+) mice had a milder phenotype of ARS compared to
the mice with homozygous mutations (Foxc1-/-). Homozygous mice exhibit excessive growth
of corneal blood and lymphatic vessels which is associated with disorganization of the extracel-
lular matrix (ECM) and increased expression of multiple matrix metalloproteinases [31]. In
the current study the patients with the homozygous in-frame deletion of three conserved ala-
nine amino acids were also affected by congenital glaucoma, high IOP (which might be due to
the disorganized ECM), pupil corneal vascularization, and mild central corneal opacification at
the level of post stroma.
Our study expands the mutation spectrum of the PAX6 and FOXC1 genes in individuals
with anterior segment dysgenesis disorders. In addition, our study suggests that FOXC1muta-
tions, besides typical autosomal dominant ARS, can also cause ARS with congenital glaucoma
through an autosomal recessive inheritance pattern. Our results thus expand the disease spec-
trum of FOXC1, and may lead to a better understanding of the role of FOXC1 in development.
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